Evaluating the Efficacy of Pervistop<sup>®</sup>, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study.

Aragona, Cesare; Bezerra Espinola, Maria Salomè; Bilotta, Gabriele; Porcaro, Giuseppina; Calcagno, Marco

Evaluating the Efficacy of Pervistop^®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study.

Aragona, Cesare; Bezerra Espinola, Maria Salomè; Bilotta, Gabriele; Porcaro, Giuseppina; Calcagno, Marco.

Afiliación

Aragona C; Systems Biology Group Lab, 00161 Rome, Italy.
Bezerra Espinola MS; Systems Biology Group Lab, 00161 Rome, Italy.
Bilotta G; Alma Res Fertility Center, 00198 Rome, Italy.
Porcaro G; Women's Health Centre, USL UMBRIA 2, 05100 Terni, Italy.
Calcagno M; Department of Woman Health and Reproductive Medicine, Santo Spirito Hospital, 00193 Rome, Italy.

J Clin Med ; 12(6)2023 Mar 10.

Article en En | MEDLINE | ID: mdl-36983172

Palabras clave

ASCUS; EGCG; HPV; LSIL; folic acid; hyaluronic acid; persistence; vitamin B12

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google